REPORT ID 713

Asia-Pacific Polio Vaccines Market Report 2017

Publish Date
01-Dec-17
Pages
104
Format
Electronic (PDF)

In this report, the Asia-Pacific Polio Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Polio Vaccines for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Polio Vaccines market competition by top manufacturers/players, with Polio Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Astellas Pharma
    CSL
    Emergent BioSolutions
    GlaxoSmithKline
    Johnson & Johnson
    MedImmune
    Merck
    Pfizer
    Sanofi Pasteur
    Serum Institute

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    IPV (Inactivated Poliovirus Vaccine)
    OPV (Oral Polio Vaccine)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Age (0-1)
    Age Above 1

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Polio Vaccines Market Report 2017
1 Polio Vaccines Overview
    1.1 Product Overview and Scope of Polio Vaccines
    1.2 Classification of Polio Vaccines by Product Category
        1.2.1 Asia-Pacific Polio Vaccines Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Polio Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 IPV (Inactivated Poliovirus Vaccine)
        1.2.4 OPV (Oral Polio Vaccine)
    1.3 Asia-Pacific Polio Vaccines Market by Application/End Users
        1.3.1 Asia-Pacific Polio Vaccines Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Age (0-1)
        1.3.3 Age Above 1
    1.4 Asia-Pacific Polio Vaccines Market by Region
        1.4.1 Asia-Pacific Polio Vaccines Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Polio Vaccines (2012-2022)
        1.5.1 Asia-Pacific Polio Vaccines Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Polio Vaccines Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Polio Vaccines Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Polio Vaccines Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Polio Vaccines Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Polio Vaccines Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Polio Vaccines (Volume and Value) by Type
        2.2.1 Asia-Pacific Polio Vaccines Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Polio Vaccines Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Polio Vaccines (Volume) by Application
    2.4 Asia-Pacific Polio Vaccines (Volume and Value) by Region
        2.4.1 Asia-Pacific Polio Vaccines Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Polio Vaccines Revenue and Market Share by Region (2012-2017)

3 China Polio Vaccines (Volume, Value and Sales Price)
    3.1 China Polio Vaccines Sales and Value (2012-2017)
        3.1.1 China Polio Vaccines Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Polio Vaccines Revenue and Growth Rate (2012-2017)
        3.1.3 China Polio Vaccines Sales Price Trend (2012-2017)
    3.2 China Polio Vaccines Sales Volume and Market Share by Type
    3.3 China Polio Vaccines Sales Volume and Market Share by Application

4 Japan Polio Vaccines (Volume, Value and Sales Price)
    4.1 Japan Polio Vaccines Sales and Value (2012-2017)
        4.1.1 Japan Polio Vaccines Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Polio Vaccines Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Polio Vaccines Sales Price Trend (2012-2017)
    4.2 Japan Polio Vaccines Sales Volume and Market Share by Type
    4.3 Japan Polio Vaccines Sales Volume and Market Share by Application

5 South Korea Polio Vaccines (Volume, Value and Sales Price)
    5.1 South Korea Polio Vaccines Sales and Value (2012-2017)
        5.1.1 South Korea Polio Vaccines Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Polio Vaccines Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Polio Vaccines Sales Price Trend (2012-2017)
    5.2 South Korea Polio Vaccines Sales Volume and Market Share by Type
    5.3 South Korea Polio Vaccines Sales Volume and Market Share by Application

6 Taiwan Polio Vaccines (Volume, Value and Sales Price)
    6.1 Taiwan Polio Vaccines Sales and Value (2012-2017)
        6.1.1 Taiwan Polio Vaccines Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Polio Vaccines Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Polio Vaccines Sales Price Trend (2012-2017)
    6.2 Taiwan Polio Vaccines Sales Volume and Market Share by Type
    6.3 Taiwan Polio Vaccines Sales Volume and Market Share by Application

7 India Polio Vaccines (Volume, Value and Sales Price)
    7.1 India Polio Vaccines Sales and Value (2012-2017)
        7.1.1 India Polio Vaccines Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Polio Vaccines Revenue and Growth Rate (2012-2017)
        7.1.3 India Polio Vaccines Sales Price Trend (2012-2017)
    7.2 India Polio Vaccines Sales Volume and Market Share by Type
    7.3 India Polio Vaccines Sales Volume and Market Share by Application

8 Southeast Asia Polio Vaccines (Volume, Value and Sales Price)
    8.1 Southeast Asia Polio Vaccines Sales and Value (2012-2017)
        8.1.1 Southeast Asia Polio Vaccines Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Polio Vaccines Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Polio Vaccines Sales Price Trend (2012-2017)
    8.2 Southeast Asia Polio Vaccines Sales Volume and Market Share by Type
    8.3 Southeast Asia Polio Vaccines Sales Volume and Market Share by Application

9 Australia Polio Vaccines (Volume, Value and Sales Price)
    9.1 Australia Polio Vaccines Sales and Value (2012-2017)
        9.1.1 Australia Polio Vaccines Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Polio Vaccines Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Polio Vaccines Sales Price Trend (2012-2017)
    9.2 Australia Polio Vaccines Sales Volume and Market Share by Type
    9.3 Australia Polio Vaccines Sales Volume and Market Share by Application

10 Asia-Pacific Polio Vaccines Players/Suppliers Profiles and Sales Data
    10.1 Astellas Pharma
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Polio Vaccines Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Astellas Pharma Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 CSL
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Polio Vaccines Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 CSL Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Emergent BioSolutions
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Polio Vaccines Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Emergent BioSolutions Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 GlaxoSmithKline
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Polio Vaccines Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 GlaxoSmithKline Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Johnson & Johnson
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Polio Vaccines Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Johnson & Johnson Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 MedImmune
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Polio Vaccines Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 MedImmune Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Merck
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Polio Vaccines Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Merck Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Pfizer
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Polio Vaccines Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Pfizer Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Sanofi Pasteur
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Polio Vaccines Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Sanofi Pasteur Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Serum Institute
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Polio Vaccines Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Serum Institute Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview

11 Polio Vaccines Manufacturing Cost Analysis
    11.1 Polio Vaccines Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Polio Vaccines

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Polio Vaccines Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Polio Vaccines Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Polio Vaccines Market Forecast (2017-2022)
    15.1 Asia-Pacific Polio Vaccines Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Polio Vaccines Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Polio Vaccines Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Polio Vaccines Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Polio Vaccines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Polio Vaccines Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Polio Vaccines Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Polio Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Polio Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Polio Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Polio Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Polio Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Polio Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Polio Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Polio Vaccines Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Polio Vaccines Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Polio Vaccines Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Polio Vaccines Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Polio Vaccines Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer